Elon Musk’s Neuralink says the FDA has approved a first-in-human clinical trial for its brain-computer interface technology. Neuralink said on Twitter yesterday: “We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study! This is the result of incredible work by the Neuralink team in close collaboration with […]
Neurological
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management
ClearPoint Neuro enters drug delivery licensing deal with UCB
ClearPoint Neuro (Nasdaq:CLPT) announced today that it entered into a multi-year license agreement with UCB over gene therapy delivery. Solana Beach, California-based ClearPoint Neuro develops a therapy-enabling platform providing navigation and delivery to the brain. The licensing agreement with UCB establishes a partnership on delivery platforms for UCB’s gene therapy portfolio. Get the full story […]
Research supports brain-computer interface tech from Onward
Onward Medical announced today that published data demonstrates the ability of its wireless brain-computer interface (BCI). The data, published in Nature, demonstrates how the BCI uses thought to modulate ARC therapy. Researchers say that, when paired with ARC therapy, an implanted BCI allowed an individual to gain augmented control over when and how he moved […]
Stryker announces first completed cases with brain surgery guidance platform
Stryker (NYSE:SYK) announced today that surgeons began early product surveillance cases for its Q Guidance system with cranial guidance software. Kalamazoo, Michigan-based Stryker designed the Q Guidance System as an image-based planning and intraoperative platform. The company launched the system for spinal applications in September 2022. This latest iteration offers support for cranial surgeries. Stryker received […]
Cala Health, Cue Health have layoffs in California
Cala Health and Cue Health (Nasdaq:HLTH) both recently filed with the state of California to confirm reductions in their workforces. The two companies are the latest to join the long list of medtech companies cutting employees amid a challenging time for the industry. To date, MassDevice has reported on more than 18,000 medtech employees who have been […]
Cadence Neuroscience raises $26M to support epilepsy neuromod therapy
Neurmodulation technology developer Cadence Neuroscience announced that it secured $26 million in a Series B financing round. The Angelini Lumira Biosciences Fund led the round. It also included new investors F-Prime Capital, LivaNova USA, Angelini Ventures, Spectrum Financial Services and Mayo Clinic. Series A lead investor, Jazz Venture Partners, also contributed. In connection with the […]
Paradromics raises $33M, wins FDA breakthrough nod for brain-computer interface tech
Paradromics announced today that it raised $33 million in a Series A funding round and garnered an FDA breakthrough device designation. Austin, Texas-based Paradromics develops a high data-rate brain-computer interface (BCI). The company sees its latest financial and regulatory progress as a positive step into the competitive BCI market. Paradromics plans to use the funding […]
First clinical case performed with NeuroOne Evo sEEG, Zimmer Biomet Rosa One Brain
NeuroOne Medical Technologies (Nasdaq:NMTC) today announced the first clinical case performed with its Evo sEEG in robotic neurosurgery. Dr. William Bingaman performed the procedure with the electrode — exclusively marketed by Zimmer Biomet — at Cleveland Clinic. It marks the first procedure to utilize NeuroOne’s Evo sEEG with Zimmer Biomet’s Rosa One Brain. The Rosa […]
FDA approves Abbott spinal cord stimulation devices for non-surgical back pain
Abbott (NYSE:ABT) announced today that it received FDA approval for the use of its spinal cord stimulation devices (SCS) for certain people with back pain. The FDA approval applies to the treatment of chronic back pain in those who have not had or are not eligible to receive back surgery. This is also known as […]
Onward completes first-in-human use of movement-restoring lead
Onward Medical announced today that it successfully completed the first-in-human use of its investigational ARC-IM lead. Eindhoven, the Netherlands-based Onward designed the lead to restore movement, function and independence in people with spinal cord injury (SCI). The company developed ARC-IM to deliver targeted electrical pulses to the spinal cord. It represents a key component of […]
BrainsWay launches study program to evaluate neurostim tech
BrainsWay (Nasdaq:BWAY) announced today that it launched an investigator-initiated study (IIS) program for its Deep TMS technology. The company designed the program to support further research for Deep TMS (transcranial magnetic stimulation) by the clinical research community. According to a news release, BrainsWay plans to utilize data collaboration and equipment loan initiatives. The company accepts […]